Nicotinamide N-methyltransferase enhances paclitaxel resistance in ovarian clear cell carcinoma

Author:

Kikuchi-Koike Ryoko1,Sakamoto Masaru2,Sasajima Yuko1,Miyagawa Yuko1,Uozaki Hiroshi1,Umayahara Kenji2,Hashimoto Kei1,Takahashi Yuko1,Takasaki Kazuki1,Kihira Chikara1,Nishida Haruka1,Ichinose Takayuki1,Hirano Mana1,Hiraike Haruko1,Nagasaka Kazunori1

Affiliation:

1. Teikyo University School of Medicine

2. Sasaki Foundation Kyoundo Hospital

Abstract

Abstract

Background. Growing evidence suggests that nicotinamide N-methyltransferase (NNMT), an S-adenosyl-L-methionine (SAM)-dependent cytosolic enzyme, plays an essential role in cancer progression. Recently, it was reported that NNMT is involved in methylation metabolism and tumorigenesis and is associated with poor prognosis in a number of cancers. It has also been reported that NNMT is overexpressed in the stroma of advanced high-grade serous carcinomas and may contribute to poor survival. The aim of this study was to identify novel biomarkers that predict resistance in paclitaxel-resistant advanced or recurrent ovarian clear cell carcinoma (OCCA) and to evaluate their clinicopathologic significance. Methods. Four OCCA cell lines (ES-2, KK, OVMANA, and OVTOKO) were divided into paclitaxel high and low sensitivity groups by WST-8 assay and fluorescence-labeled two-dimensional electrophoresis (2D-DIGE) was performed. Protein spots with different expression intensities in each drug-sensitive group were analyzed by mass spectrometry to identify the proteins. Results. NNMT was detected as a protein molecule upregulated in the paclitaxel-resistant group, and knockdown by NNMT siRNA increased paclitaxel sensitivity in the NNMT-expressing ovarian clear cell carcinoma cell lines OVTOKO and RMG1. Furthermore, in analysis of clinical tissue samples, no deaths were observed in 7 patients with low NNMT expression in the cytoplasm of cancer cells. Conclusions. High NNMT expression in the cytoplasm of cancer cells is associated with low sensitivity to paclitaxel in OCCA and may have prognostic implications; knockdown of NNMT expression also reduced paclitaxel efficacy. Therefore, targeted therapies that reduce cytoplasmic NNMT expression levels may increase the sensitivity of OCCA to paclitaxel.

Publisher

Springer Science and Business Media LLC

Reference22 articles.

1. Cancer statistics, 2022;Siegel RL;CA Cancer J Clin,2022

2. Clear cell carcinoma of the ovary: Epidemiology, pathological and biological features, treatment options and clinical outcomes;Gadducci A;Gynecol Oncol,2021

3. Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers;Ceppi L;Gynecol Oncol,2021

4. Ovarian Cancer: An Overview;Penny SM;Radiol Technol,2020

5. Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin;Sirichaisutdhikorn D;Asian Pac J Cancer Prev,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3